Split History
RDHL split history picture
Redhill Biopharma Ltd Ramat Gan (RDHL) has 1 split in our RDHL split history database. The split for RDHL took place on March 23, 2023. This was a 1 for 40 reverse split, meaning for each 40 shares of RDHL owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 25 share position following the split.

When a company such as Redhill Biopharma Ltd Ramat Gan conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the RDHL split history from start to finish, an original position size of 1000 shares would have turned into 25 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Redhill Biopharma Ltd Ramat Gan shares, starting with a $10,000 purchase of RDHL, presented on a split-history-adjusted basis factoring in the complete RDHL split history. RDHL split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/15/2014
End date: 04/12/2024
Start price/share: $566.00
End price/share: $0.42
Dividends collected/share: $0.00
Total return: -99.92%
Average Annual Total Return: -51.30%
Starting investment: $10,000.00
Ending investment: $7.50
Years: 10.00
RedHill Biopharma is a biopharmaceutical company that focuses on commercialization and development of proprietary drugs for gastrointestinal (GI) diseases. The ongoing development programs of Co.'s therapeutic candidates, most in late-stage clinical development, include: RHB-204, which is for the treatment of mycobacterium avium complex disease; RHB-104, which is an investigational drug intended to treat Crohn's disease; RHB-102 (Bekinda®), which is an investigational once-daily bi-modal extended-release oral formulation of ondansetron; and RHB-106, which is an investigational tablet intended for the preparation and cleansing of the GI tract prior to the performance of abdominal procedures. According to our RDHL split history records, Redhill Biopharma Ltd Ramat Gan has had 1 split.
Date Ratio
03/23/20231 for 40
RDHL is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

RDNT Split History
RDY Split History
REPH Split History
RGLS Split History
RHE Split History
RMD Split History
RMTI Split History
RNN Split History
RNVA Split History
ROCM Split History

Email EnvelopeFree RDHL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

WiSA Technologies, Inc. (WISA)
C3IS INC. (CISS)
Fluent, Inc. (FLNT)
TRACON Pharmaceuticals (TCON)
Agenus Inc. (AGEN)
Marin Software Incorporated (MRIN)
Nutex Health Inc. (NUTX)
Allarity Therapeutics, Inc. (ALLR)
Palisade Bio, Inc. (PALI)
Smith Micro Software, Inc. (SMSI)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

RDHL Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.